Page 10 - SAMRC Annual Report 2024-2025
P. 10

ACHIEVEMENTS AND HIGHLIGHTS





            Supporting Health Research                         all priority areas to address national health needs,
            and Innovation Ecosystems                          including during pandemics.
            in South Africa Through                            The  SAMRC’s  Grants  Innovation  and  Product

            Strategic Partnerships                             Development (GIPD) unit has been particularly
                                                               focused on  building research and innovation
            The  SAMRC  plays  a  particularly  important  role
            in supporting and building the national health     ecosystems for vaccines, medical devices and
            research  and  innovation  system  in  South  Africa   diagnostics and indigenous knowledge system/
            through its core functions of conducting research,   plant-based medicines. Key to this has been
            funding research and supporting research capacity   the establishment of local and international
            development, innovation and research translation.   partnerships for funding and general ecosystem
            Its funding and innovation activities in 2024 focused   participation and support.
            substantially on driving an ecosystem approach
            to ensure that the organisation not only supports   Vaccines Research and
            cutting edge research but is also able to facilitate   Innovation Ecosystem
            the translation of this research into policy, products
            and practice. Fully capacitated and well-coordinated   South Africa has established, through decades of R&D
            ecosystems  enable  aligned  and  efficient  research   and infrastructure investments, a Vaccines Research
            and development efforts that can be applied in     and Innovation Ecosystem that is depicted below.




               VACCINES VALUE CHAIN






                                                   Carriers/       2 Species
                                                   Adjuvants    Challenge Models
                  Genomic                           Vaccine
                surveillance and    Immunogen      Candidate       Preclinical      Process        Clinical Grade
                   Analysis        Design         Development       Testing        Development     Manufacture
                                                   Vaccine        Immunology        Process        Enzymes for
                                                   Platforms      Assessment       Optimisation    production












                                 Human Resource
                                  Development
                                                                         Chan Soon-Shiong Family Foundation




               Depiction of the vaccine development value chain and ecosystem in South Africa





            8           SAMRC  ANNUAL REPOR T 2024-25
   5   6   7   8   9   10   11   12   13   14   15